- Much more than 400,000 Excedrin bottles have been recalled due to a producing challenge.
- According to the recall, selected bottles of the migraine medicine contain holes in the bottom that could be a danger for poisoning amid children with straightforward accessibility to the capsules.
- No accidents have been reported.
- Check out Company Insider’s homepage for extra stories.
About 433,600 models of Excedrin bottles have been recalled thanks to a packaging problem that has left holes in several bottles.
Five Excedrin brands — migraine caplets, migraine geltabs, excess toughness caplets, PM headache caplets, and stress headache caplets — are provided in the recall, which was posted on December 23.
According to GlaxoSmithKline (GSK), which manufactures Excedrin, certain bottles of the migraine medication comprise holes in the base that could induce a poisoning risk between small children with effortless accessibility to the tablets. The Poison Prevention Packaging Act demands that substances made up of aspirin and acetaminophen, like Excedrin, should be protected with child-resistant packaging.
The Consumer Products Protection Commission website states bottles devoid of a gap can go on to be applied usually.
GSK said on its site that 24-rely bottles of Excedrin additional toughness caplets and Excedrin migraine caplets and geltabs have been not impacted.
No injuries have been claimed, according to United states Currently